@windhamvp

ClarVista HARMONI® Receives CE Mark for Europe

Aliso Viejo, CA — ClarVista Medical, Inc., a privately-held ophthalmic device company, announced today it received CE (Conformite Europeenne) Mark of the HARMONI Modular Intraocular Lens (IOL) System for the … Continued

Enumeral Announces Identification of Anti-PD-1 Antibodies with Potential for Differentiated Mechanism of Action

Provides Update on Additional Antibody Programs Against TIM-3 and LAG-3 Cambridge, Mass.–Enumeral Biomedical Holdings, Inc. (OTCQB:ENUM), a biotechnology company focused on discovering and developing novel antibody immunotherapies that help the … Continued

NovoCure Limited Announces Launch of Initial Public Offering

St. Helier, Jersey – NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares … Continued

Windham portfolio company NeoTract featured in Men’s Health Supplement of USA TODAY

  What Are Your Treatment Options for an Enlarged Prostate? PREVENTION AND TREATMENT If you’re losing sleep over the symptoms associated with benign prostatic hyperplasia, you are not alone—1 in … Continued

NICE Evaluation and Tariff Code Announcements to Increase UroLift® System Availability in UK NHS Patients with Enlarged Prostate

National Institute for Health and Care Excellence (NICE) could give major boost to UroLift® System adoption on the NHS across the UK with guidance finding the treatment is less costly … Continued